Table 1.
Variable | All Patients (n = 10,302) |
---|---|
Median (IQR) | |
Age (years) | 71 (12) |
Hospital volume† | 103 (141) |
Number (%) | |
Male | 4727 (45.88) |
Race | |
White | 8835 (85.76) |
Black | 333 (3.23) |
Asian / Pacific Islander | 215 (2.09) |
Native American | 51 (0.49) |
Other | 777 (7.54) |
Unknown | 91 (0.88) |
Ethnicity | |
Non-Hispanic | 8900 (86.39) |
Hispanic | 1309 (12.71) |
Unknown | 93 (0.90) |
Insurance | |
Medicare | 7433 (72.15) |
Private | 1831 (17.77) |
Medi-Cal | 393 (3.81) |
Workers’ compensation | 518 (5.02) |
Other | 127 (1.23) |
Medical comorbidities | |
Diabetes mellitus without complications | 739 (7.17) |
Diabetes mellitus with complications | 662 (6.43) |
Coronary atherosclerosis | 719 (6.98) |
Morbid obesity | 664 (6.45) |
COPD | 700 (6.79) |
Chronic kidney disease, mild | 682 (6.62) |
Chronic kidney disease, moderate | 621 (6.03) |
Chronic kidney disease, severe | 553 (5.37) |
Chronic kidney disease requiring dialysis | 549 (5.33) |
Vascular disease | 662 (6.43) |
Other circulatory disease | 623 (6.05) |
Acute renal failure | 650 (6.31) |
Cardio-respiratory failure | 603 (5.85) |
Major depressive or bipolar disorder | 636 (6.17) |
Major fracture (except skull) | 574 (5.57) |
Hip fracture or dislocation | 554 (5.38) |
Protein-calorie malnutrition | 573 (5.56) |
Metastatic cancer or leukemia | 544 (5.28) |
Complications of implants | 708 (6.87) |
History of prior complications | 595 (5.78) |
Osteoarthritis of hip or knee | 737 (7.15) |
Osteoporosis | 667 (6.47) |
History of bone/joint/muscle infection | 589 (5.72) |
Mean (SD) | |
Number of comorbidities | 0.34 (1.19) |
IQR = interquartile range; COPD = chronic obstructive pulmonary disease; SD = standard deviation
† Cases of primary aTSA performed between 10/1/2015 and 12/13/2017